The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should see earnings gains through the end of the decade.

Eli Lilly’s Zepbound transformed weight loss drug market since debut 18 months ago 4.5 million people reportedly taking Lilly ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Weight loss drugs helped me lose 85 pounds — and quieted my alcohol cravings Johnna Byrd swapped boozing and fast food for cute gym outfits.

What To Know Previous law had offered some coverage for infertility treatment but had excluded IVF treatment. The new bill will require large and small group health care service plan contracts and ...

VK2375 is a dual GLP-1/GIP receptor agonist similar to Eli Lilly 's blockbuster weight loss drug Zepbound. Viking is developing VK2375 in both subcutaneous (under the skin) and oral formulations.

Gov. Jeff Landry struck language from the Louisiana budget plan that could have provided state employees and public school teachers with insurance coverage for popular weight-loss medication over the ...

An analysis reveals that nearly two-thirds of patients who started on Wegovy or Zepbound were still taking them a year later. The persistence rate has increased, suggesting improved insurance coverage ...

CVS owes millions for overbilling PHILADELPHIA — The U.S. secured a partial judgment in its favor on claims that CVS’s pharmacy benefit management subsidiary, Caremark, overbilled Medicare through ...